期刊文献+

2型糖尿病患者非糖尿病一级亲属血清铁蛋白检测的临床意义 被引量:1

Clinical meaning of nondiabetic first-degree relatives' serum ferritin of type 2 diabetes mellitus
暂未订购
导出
摘要 目的探讨2型糖尿病非糖尿病一级亲属高危人群血清铁蛋白的临床意义。方法将糖尿病患者、糖耐量异常者、糖耐量正常的一级亲属、无糖尿病家族史且糖耐量正常者分为A、B、C、D四组;对所有受试者进行血清铁蛋白(SF)、OGTT、胰岛素释放试验等,用稳态模型(HOMA)公式来评估胰岛抵抗(IR)和胰岛素分泌功能。结果 (1)男性铁蛋白含量明显高于女性;(2)血清铁蛋白测定值由高到低次序是A、B、C、D组;(3)A、B、C组分别于D组比较,P<0.01。结论 SF升高有可能是早期糖代谢紊乱的有效预报因子,检测SF有助于更早发现潜在的糖尿病患者。 Objective To explore the clinical meaning of serum ferritin of nondiabetic first-degree relatives high risk group of type 2 diabetes mellitus(T2DM).Methods Patients with diabetes,impaired glucose tolerance,first-degree relatives with normal glucose tolerance and normal glucose tolerance without family history of diabetes were divided into group A,B,C,D;SF,OGTT and Insulin release test were made for all subjects,and steady-state model formula(HOMA) was used to e valuate insulin resistance(IR) and secretory function of insulin.Results(1)Male ferritin content was obviously higher than that of female;(2)The measured values of serum ferritin ranked from high to low:group A,group B,group C,group D;(3)group A,B and C were compared with group D,P 〈0.01.Conclusion SF may be an effective predictor of disturbance of early carbohydrate metabolism.Detection of SF can helps to earlier find potential diabetic patients.
作者 黎淑馨
出处 《中国当代医药》 2012年第35期36-37,共2页 China Modern Medicine
关键词 糖尿病 铁蛋白 一级亲属 血清 Diabetes mellitus Ferritin First-degree relatives Serum
  • 相关文献

参考文献6

二级参考文献15

  • 1Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among US adults [ J ]. Diabetes Care, 1999,22 (12) : 1978-1983.
  • 2Salonen JT, Tuomainen TP, Nyyssonen K, et al. Relation between iron stores and non-insulin dependent diabetes in men : case-control study [ J ]. BMJ, 1998,317 ( 9 ) : 727-730.
  • 3Sharifi F, Sazandeh SH. Serum ferritin in type 2 diabetes mellitus and its relationship with HbAlc[ J]. Acta Medica Iranica, 2004,42 ( 2 ) : 142-145.
  • 4Ren Y, Tian H, Liang J, Zhao G. Elevated serum ferritin concentration in a glucose impaired population and in norreal glucose tolerance first degree relatives in familial type 2 diabetic pedigrees [ J ]. Diabetes Care, 2004,27 ( 4 ) : 622-623.
  • 5Haap M, Fristsehe A, Mensing I/J, et al. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people [ J ]. Ann Int Med ,2003,139(6) :869-871.
  • 6Kato I, Dnistrian AM, Schwartz Met al. Risk of iron overload among middle-aged women [ J ]. lnt J Vitam Res, 2000,70(3) :119-125.
  • 7Tuomainen TP, Nyyssonen K, Salonen R et al. Body iron stores are associated with serum insulin and blood glucose concentration: population study in 1,013 eastern Finnish men [ J ]. Diabetes Care, 1997,20 ( 3 ) :426-428.
  • 8Gerich JE. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev, 1998, 19:491-503.
  • 9Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man:measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest, 1981, 68:1456-1467.
  • 10Ryder E, Gomez ME, Fernandez V, et al. Presence of impaired insulin secretion and insulin resistance in normoglycemic male subjects with family history of type 2 diabetes. Diabetes Res Clin Pract, 2003, 60:95-103.

共引文献70

同被引文献17

  • 1Nogueira-Machado JA, Chaves MM. From hyperglycemia to AGE- RAGE interaction on the cell surface:a dangerous metabolic route for diabetic patients [ J ]. Expert Opin Ther Targets,2008,12 ( 7 ) : 871-882.
  • 2Hudson BI, Wendt T, Bucciarelli LG, et al. Diabetic vascular disease : it' s all the RAGE [ J ]. Antioxid Redox Signal, 20'0'5,7 (11-12) :1588-1600.
  • 3Rimasamy R ;Yan SF ; $chmidt AM, Receptor for AGE (RAGE) : signaling mechanisms in the pt}i6ghesis oT diabetes and it complications[J]. Ann N Y Acad Sci,243:88-102.
  • 4Prevost G, Fajardy I, Besmond C, et al. Polymorphisms of tle receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients [ J ]. Diabetes Metab,2005,31 ( 1 ) :35-39.
  • 5Yamamoto Y, Kato I, Doi T,et al. Development and prevention f advanced diabetic nephropathy in RAGE-overexpresSing /iaic6 [J]. J Clin Invest,2001, 108(2):261-268.
  • 6Patowary S. Pharmacogenomics-therapeutic and ethical issues [ J]. Kathmandu Univ Med J (KUMJ) ,2005,3 (4) :428-430.
  • 7Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction [ J ]. Circ ReM, 2004,95 ( 3 ) : 233 - 238.
  • 8Leuner B, Max M, Thamm K, et al. RAGE influetlc/s Igity iN mice. Effects of the presence of RAGE on weight gain, AGE accumulation,and insulin levels in mice on a high fat diet [ J ]. Z Gerontol Geriatr,2012,45 ( 2 ) : 102-108.
  • 9Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products[ J]. J Mol Med (Berl) ,2005,83 ( 11 ) :876-886.
  • 10Sugimoto K, Yasujima M, Yagihashi S. Role of advanced glycation end products in diabetic neuropathy[ J]. Curr Pharm Des,2008, 14(10) :953-961.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部